New drug approval pathway benefits industry over patients, argues expert
A new UK drug approval pathway, designed to speed up the availability of new medicines, benefits industry over patients and the NHS, argues an expert in The BMJ today. The […]
A new UK drug approval pathway, designed to speed up the availability of new medicines, benefits industry over patients and the NHS, argues an expert in The BMJ today. The […]
The European Medicines Agency (EMA) has given its approval for six new medicines, with another nine products receiving extensions for their therapeutic indications. The decisions came as the […]
The European Medicines Agency’s key committee on human medicines (CHMP) recommended ten medicines for approval at its November 2025 meeting. This brings to 97 the total number of […]
The European Medicines Agency’s (EMA) key expert group has recommended 13 medicines for approval at its June 2025 meeting. The Committee on Medicinal Products for Human Use (CHMP) […]
The European Medicines Agency (EMA) has recommended four new products for approval, and extended the use of sixteen other drugs. The decisions, which brings to 12 the total […]
Drug development is currently an extremely long, expensive and inefficient process. Findings generated in a lab are often very hard to replicate once translated into animal models or […]
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.
